<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sleep in children and adolescents with attention deficit hyperactivity disorder</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sleep in children and adolescents with attention deficit hyperactivity disorder</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Sleep in children and adolescents with attention deficit hyperactivity disorder</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna Ivanenko, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald D Chervin, MD, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H994608435"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Attention deficit hyperactivity disorder (ADHD) is a disorder that manifests in childhood with symptoms of inattention, hyperactivity, and impulsiveness [<a href="#rid1">1,2</a>]. These symptoms can affect cognitive, academic, behavioral, emotional, and social functioning. It is a common disorder, diagnosed in approximately 5 percent of children and adolescents [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Diagnostic criteria'</a>.)</p><p>Sleep disturbances are common among children with ADHD. The association is complex and most likely bidirectional; ADHD and its treatment appear to promote sleep disturbances, while disrupted or inadequate sleep can contribute to ADHD symptoms. The evaluation and management of children with ADHD and sleep complaints will be discussed in this topic review. Other topic reviews with related material include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16927.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications"</a>.)</p><p></p><p class="headingAnchor" id="H1431082239"><span class="h1">SLEEP PROBLEMS IN CHILDREN WITH ADHD</span></p><p class="headingAnchor" id="H1687170710"><span class="h2">Common sleep complaints</span><span class="headingEndMark"> — </span>Sleep disturbances have been reported in as many as 70 percent of children with ADHD, although this rate varies widely depending upon the method and definitions used to measure the sleep problems [<a href="#rid4">4-6</a>]. Most studies that document subjective sleep complaints utilize sleep diaries, brief screening questionnaires like the BEARS survey  (<a class="graphic graphic_table graphicRef94931" href="/d/graphic/94931.html" rel="external">table 1</a>) [<a href="#rid7">7</a>], or validated survey instruments such as the Children's Sleep Habits Questionnaire (CSHQ) [<a href="#rid8">8</a>], Children's Sleep Behavior Scale (CSBS) [<a href="#rid9">9</a>], or Pediatric Sleep Questionnaire Sleep-Related Breathing Disorders (PSQ-SRBD) Scale [<a href="#rid10">10</a>].</p><p>In these studies, common sleep complaints include [<a href="#rid11">11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Bedtime resistance</p><p class="bulletIndent1"><span class="glyph">●</span>Sleep-onset difficulties</p><p class="bulletIndent1"><span class="glyph">●</span>Night awakenings</p><p class="bulletIndent1"><span class="glyph">●</span>Difficulty with morning awakenings</p><p class="bulletIndent1"><span class="glyph">●</span>Sleep-related breathing problems</p><p class="bulletIndent1"><span class="glyph">●</span>Daytime sleepiness</p><p></p><p>Other sleep problems reportedly associated with ADHD in children and adolescents include difficulties with sleep maintenance, increased nocturnal motor activity, snoring, restless sleep, parasomnias, nightmares, delayed sleep-wake phase, short sleep time, and nocturnal anxiety [<a href="#rid12">12-15</a>]. Home confinement associated with the COVID-19 pandemic has exacerbated many of these complaints [<a href="#rid16">16</a>], and children with evening chronotypes may be particularly vulnerable [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H1549490155"><span class="h2">Objective sleep measures</span><span class="headingEndMark"> — </span>Other studies use objective measures to assess physiologic characteristics of sleep in children with ADHD, including polysomnography (PSG), actigraphy, and the multiple sleep latency test (MSLT). Compared with a healthy population, sleep in children and adolescents with ADHD is more likely to have the following abnormalities:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limb movements</strong> – Increased prevalence of restless legs syndrome (RLS), and the associated phenomenon of periodic limb movements of sleep, sometimes sufficient in the absence of RLS to diagnose periodic limb movement disorder (PLMD) [<a href="#rid18">18-20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive sleep apnea (OSA)</strong> – Increased prevalence of sleep-disordered breathing (increased apnea-hypopnea index) [<a href="#rid11">11,19</a>]. One systematic review reported OSA in 20 to 30 percent of children with ADHD, compared with approximately 3 percent in the general population [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduced or disrupted sleep time</strong> – Increased sleep onset latency, lower total sleep time, lower sleep efficiency, more stage shifts per hour of sleep, and more time in stage N1 (light) sleep [<a href="#rid11">11,22</a>]. These associations are partly but not fully explained by other factors, such as age, sex, comorbidities, and adjustments to conditions in the sleep laboratory (sometimes known as the first-night effect).</p><p></p><p>Studies of daytime sleepiness (measured by sleep latency on the MSLT) have had mixed results. Two studies reported significantly reduced mean sleep latency compared with controls, indicating increased sleep propensity during the day [<a href="#rid19">19,23</a>]. However, other studies found no significant differences in MSLT measures, with some inter-test variability among children with ADHD [<a href="#rid24">24,25</a>]. These variable results are consistent with the observation that children with ADHD have variable physiologic phenotypes, in that some children tend to have lower levels of alertness compared with children without ADHD, and others do not.</p><p class="headingAnchor" id="H604158859"><span class="h2">Pathophysiology of associations</span><span class="headingEndMark"> — </span>The association between ADHD and sleep is complex. In some cases, the sleep problem may be caused or exacerbated by environmental factors (eg, poor sleep habits), stimulant medications used to manage the ADHD, or psychiatric or medical comorbidities. Conversely, disrupted or inadequate sleep may result in tiredness and daytime behavioral difficulties with focused attention, learning, and impulse regulation, which may mimic or exacerbate ADHD symptoms [<a href="#rid20">20,26-30</a>].</p><p>In some cases, inadequate sleep may be the primary problem, leading a child to qualify for a diagnosis of ADHD even though the condition may be reversible by proper diagnosis and treatment of the underlying sleep issue. As a result, children undergoing evaluation for ADHD should have a focused clinical assessment for sleep-disordered breathing, as recommended by the American Academy of Pediatrics [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/16641.html" rel="external">"Cognitive and behavioral consequences of sleep disorders in children"</a>.)</p><p class="headingAnchor" id="H3469230036"><span class="h3">Effects of ADHD medications on sleep</span><span class="headingEndMark"> — </span>ADHD medications are known to influence sleep characteristics in children and adolescents and may delay sleep onset (sleep-onset insomnia) or disrupt sleep continuity (sleep-maintenance insomnia). Effects of stimulants on sleep vary considerably between individual patients and between different medications, depending on individual vulnerability, pharmacokinetic properties of the drug, and duration of treatment.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stimulant medications</strong> – Stimulant medications such as <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a> tend to delay sleep onset and/or to decrease total sleep time in patients with ADHD [<a href="#rid32">32-34</a>]. However, there is a wide individual variability in the impact of stimulants on sleep characteristics, with sleep quality being either unaffected [<a href="#rid33">33</a>], decreased, or improved [<a href="#rid32">32,35</a>], depending on the dose schedule, type of formulation, and the patient's age. As an example, a meta-analysis of controlled trials concluded that treatment with methylphenidate compared with placebo was associated with longer sleep onset latency, lower total sleep time, and lower sleep efficiency (time spent sleeping/time in bed) [<a href="#rid36">36</a>]. Similar findings are reported for other stimulant medications such as <a class="drug drug_pediatric" data-topicid="13218" href="/d/drug information/13218.html" rel="external">dextroamphetamine</a> and <a class="drug drug_pediatric" data-topicid="13219" href="/d/drug information/13219.html" rel="external">dextroamphetamine-amphetamine</a> [<a href="#rid37">37-39</a>]. In another study, an extended-release formulation of methylphenidate showed a small negative effect on sleep during the initial treatment phase, but this effect gradually resolved during the first two weeks of treatment [<a href="#rid40">40</a>]. This finding suggests that the effects of stimulant medications on sleep may be transient and tend to resolve with longer duration of treatment.</p><p></p><p class="bulletIndent1">Paradoxically, in some children, sleep-onset insomnia could be related to insufficient stimulant medication effect in the evening, leading to inadequately controlled ADHD symptoms at bedtime. In this case, the sleep problems emerge as the result of rebound effect (ie, waning effect of the afternoon dose of medication) rather than a direct effect of the psychostimulant itself. This mechanism is suggested by case reports in which some children with sleep-onset insomnia improve after adding a low evening dose of stimulant.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonstimulant medications</strong> – <a class="drug drug_pediatric" data-topicid="13048" href="/d/drug information/13048.html" rel="external">Atomoxetine</a> is a nonstimulant medication that is used as a first-line treatment for ADHD in selected patients. Atomoxetine in comparison with stimulants generally has fewer adverse effects on sleep. In one study, parental reports indicated better sleep quality in children treated with atomoxetine compared with <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a> [<a href="#rid34">34,41</a>]; an increase in somnolence was reported in 9.9 percent of participants [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/d/html/16927.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications", section on 'Stimulants versus other medications'</a>.)</p><p></p><p class="bulletIndent1">Extended-release formulations of <a class="drug drug_pediatric" data-topicid="15555" href="/d/drug information/15555.html" rel="external">guanfacine</a> and <a class="drug drug_pediatric" data-topicid="13171" href="/d/drug information/13171.html" rel="external">clonidine</a> are selective alpha-2 adrenergic receptor agonists that are treatment options for ADHD and can be used as an adjunct to stimulant treatment or as monotherapy [<a href="#rid42">42,43</a>]. These drugs have sedating effects and may be helpful for patients with insomnia [<a href="#rid44">44</a>].</p><p></p><p class="headingAnchor" id="H1836728996"><span class="h3">Circadian rhythm disorders</span><span class="headingEndMark"> — </span>ADHD may be associated with disruption of the circadian cycle, manifested as "evening" tendencies, often with sleep-onset insomnia. When persistent and extreme, this is known as delayed sleep-wake phase disorder. In one study, children with ADHD-related insomnia in comparison with controls had delayed dim-light melatonin onset, indicating circadian phase delay [<a href="#rid45">45,46</a>]. Similarly, delayed circadian phase (evening) tendencies were reported among children with ADHD using the morning-evening preference scale, a parent-rated questionnaire [<a href="#rid47">47,48</a>]. Scores on this scale were correlated with both parental and polysomnographic measures of sleep-onset delay.</p><p class="headingAnchor" id="H2136828946"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Evaluation of a child with ADHD and sleep complaints involves the following steps:</p><p class="bulletIndent1"><span class="glyph">●</span>Characterize the sleep problem(s) and assess for behavioral contributors, circadian phase shift, and potential effects of medications</p><p class="bulletIndent1"><span class="glyph">●</span>Assess for primary sleep disorders, which may contribute to the sleep symptoms or ADHD symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Assess for comorbid psychiatric disorders, which may contribute to the symptoms and also inform medication management</p><p></p><p>Referral to the sleep specialist may be indicated when sleep-disordered breathing, sleep-related movement disorders, or abnormal daytime sleepiness are suspected. A full evaluation may require additional instrumental assessment of sleep, including overnight polysomnography (PSG), multiple sleep latency test (MSLT), or actigraphy.</p><p class="headingAnchor" id="H354002911"><span class="h2">General evaluation</span><span class="headingEndMark"> — </span>A structured sleep history assesses the sleep-wake schedule, difficulties initiating or maintaining sleep, presence of snoring, abnormal movements or behavior during sleep, and daytime symptoms (eg, sleepiness, inattentiveness, or irritability). This information helps to identify behavioral and environmental contributors to the problem and screens for possible primary sleep disorders. Useful tools include sleep logs, screening instruments like BEARS  (<a class="graphic graphic_table graphicRef94931" href="/d/graphic/94931.html" rel="external">table 1</a>), or validated questionnaire instruments such as Children's Sleep Habits Questionnaire (CSHQ). The evaluation is similar to that for children without ADHD; a stepwise approach is outlined in a separate topic review. (See  <a class="medical medical_review" href="/d/html/6357.html" rel="external">"Assessment of sleep disorders in children"</a>.)</p><p>In children with ADHD symptoms, particularly important components of the history include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sleep habits</strong> – Evaluate for healthy sleep practices, including whether the child gets an age-appropriate amount of sleep  (<a class="graphic graphic_table graphicRef109426" href="/d/graphic/109426.html" rel="external">table 2</a>), variability in the sleep schedule, sleeping environment, and bedtime routines  (<a class="graphic graphic_table graphicRef52760 graphicRef120097" href="/d/graphic/52760.html" rel="external">table 3A-B</a>). (See  <a class="medical medical_review" href="/d/html/6357.html" rel="external">"Assessment of sleep disorders in children", section on 'Insufficient sleep'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Behavioral contributors</strong> – Evaluate for environmental and behavioral factors that may contribute to the sleep problem, including problematic sleep-onset associations, inadequate limit-setting by parents/caregivers, or anxiety. Common manifestations of behavioral sleep problems include bedtime resistance, prolonged night awakenings, and delayed sleep onset, although these symptoms also may have other causes. A thorough clinical history and sleep diaries help to define these contributors and design an intervention. (See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children", section on 'Evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Circadian rhythm disturbances</strong> – Circadian rhythm disturbances are common among children with ADHD. To assess this factor, determine the child's sleep and wake schedule, whether it is regular, and whether it causes difficulties for the child and family (eg, problems with sleep onset or difficulty waking for school). For children with a significantly delayed sleep onset or inconsistent sleep schedule, a two-week sleep log with or without actigraphy can be helpful in defining circadian rhythm disturbances and designing an intervention. Circadian rhythm disturbances take several forms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sleep and wake times that are consistently later than the desired or required sleep schedule. When severe, this is known as delayed sleep-wake phase disorder. (See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children", section on 'Delayed sleep-wake phase disorder'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular sleep and wake times, including very different sleep patterns on weekends compared with weekdays or daytime napping after the age of five years. When severe, this pattern constitutes irregular sleep-wake rhythm disorder, in which the circadian system fails to consolidate periods of wakefulness and periods of sleep. As a result, multiple short sleep episodes are spread across the 24-hour day, interspersed with multiple periods of wakefulness.</p><p></p><p class="bulletIndent1">These circadian rhythm disturbances may be triggered or exacerbated by behavioral or environmental factors (eg, poor sleep hygiene, use of electronic media at night) or by medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications</strong> – Assess for medications that may affect sleep, including stimulants used to treat the ADHD and any psychoactive drugs. Careful documentation of each medication, dose, and timing is important to determine potential effects on sleep and inform decisions about medication management. (See <a class="local">'Adjustment of ADHD medications'</a> below.)</p><p></p><p class="headingAnchor" id="H1070934374"><span class="h2">Assess for primary sleep disorders</span><span class="headingEndMark"> — </span>Screening for primary sleep disorders is recommended for all children undergoing evaluation for ADHD because they are at increased risk for several types, as described above (see <a class="local">'Objective sleep measures'</a> above). Moreover, identification and treatment for a primary sleep disorder may reduce or even eliminate the ADHD symptoms because sleep disturbances can mimic or exacerbate ADHD symptoms. (See  <a class="medical medical_review" href="/d/html/16641.html" rel="external">"Cognitive and behavioral consequences of sleep disorders in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sleep-disordered breathing</strong> – Symptoms suggesting obstructive sleep apnea (OSA) include habitual snoring, often with mouth breathing and sometimes gasping for air during sleep, and witnessed apneas  (<a class="graphic graphic_table graphicRef111055" href="/d/graphic/111055.html" rel="external">table 4</a>). Children with these symptoms should be evaluated in the sleep laboratory with overnight PSG. (See  <a class="medical medical_review" href="/d/html/6363.html" rel="external">"Evaluation of suspected obstructive sleep apnea in children"</a>.)</p><p></p><p class="bulletIndent1">Referral to a specialist (ear, nose, and throat [ENT], sleep medicine, or allergy/immunology) may be indicated for additional evaluation and treatment. In children with OSA, surgical treatment with adenotonsillectomy is associated with improvements in neurobehavioral symptoms and academic performance [<a href="#rid21">21,27,49-53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD)</strong> – RLS may resemble symptoms of hyperactivity in children with ADHD. Useful questions to elicit RLS symptoms include "do your legs bother you at night?" and "do your legs ever hurt?" Children may describe RLS symptoms as a "need to kick," "like bugs crawling," or "weird/funny feelings" [<a href="#rid54">54</a>]. The symptoms begin or worsen during rest or inactivity (eg, lying down or sitting), are relieved by movement, and occur exclusively or predominantly in the evening or night  (<a class="graphic graphic_table graphicRef86837" href="/d/graphic/86837.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent1">Children with symptoms that suggest RLS should be evaluated for iron deficiency by serum ferritin. Nonpharmacologic interventions for RLS include establishment of healthy sleep habits; regular exercise; and avoidance of caffeine, alcohol, nicotine, and certain medications. Children with serum ferritin &lt;50 ng/mL may benefit from treatment with iron supplements. PLMD is diagnosed in a symptomatic child based on the finding of frequent periodic leg movements during PSG but no RLS or other sleep disorder to explain the symptoms; the disorder can be treated in a manner similar to RLS. (See  <a class="medical medical_review" href="/d/html/16995.html" rel="external">"Restless legs syndrome and periodic limb movement disorder in children"</a>.)</p><p></p><p class="headingAnchor" id="H4092631679"><span class="h2">Assess for comorbid psychiatric disorders</span><span class="headingEndMark"> — </span>Children and adolescents with ADHD exhibit a high rate of coexisting psychiatric disorders, which may manifest as or contribute to sleep problems [<a href="#rid13">13</a>]. Important considerations include (see  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Evaluation for coexisting disorders'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oppositional defiant disorder (ODD)</strong> – Children with the hyperactive subtype of ADHD are at increased risk for developing ODD, which may manifest with reluctance to follow rules at bedtime. ODD is thought to be a consequence of the child's hyperactivity and impulsive response style, which is perpetuated by responses from adults.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anxiety disorders</strong> – Separation anxiety may present with bedtime resistance/bed refusal or nocturnal anxiety with fear of being left alone and being attacked or kidnapped during sleep. Children with generalized anxiety disorder are also prone to the psychophysiologic subtype of chronic insomnia (also known as "conditioned" insomnia), which is characterized by anxiety specifically about falling or staying asleep. (See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children", section on 'Conditioned insomnia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Depression</strong> – Children with ADHD are at increased risk for depressed mood, characterized by negative ruminating thoughts, which may lead to sleep-onset delay, nocturnal awakenings, and difficulty getting up in the morning. The incidence of depression increases with age and especially adolescence.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Substance use</strong> – Adolescents with newly diagnosed ADHD should be assessed for substance use/abuse [<a href="#rid31">31</a>]. Substance use may complicate the clinical presentation of insomnia. Any substance use disorder can disrupt sleep patterns due to disruption of daily routines. Some substances such as alcohol and stimulants also have direct effects on insomnia.</p><p></p><p>In addition, bipolar disorder often presents during adolescence, and sometimes in younger children, and may be initially misdiagnosed as ADHD. Symptoms may include an increased level of energy in the evening with reduced need for sleep. A distinguishing feature is that individuals with bipolar disorder are not distressed by their insomnia, whereas this is not the case for children with ADHD. Other features that help to distinguish bipolar disorder from ADHD are summarized in the table  (<a class="graphic graphic_table graphicRef84012" href="/d/graphic/84012.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/d/html/83083.html" rel="external">"Pediatric bipolar disorder: Assessment and diagnosis"</a>.)</p><p class="headingAnchor" id="H1309129768"><span class="h1">MANAGEMENT OF SLEEP PROBLEMS IN ADHD</span><span class="headingEndMark"> — </span>Treatment of sleep disturbances associated with ADHD should be individualized, recognizing the child's developmental needs for sleep, behavioral issues, parent/caregiver-child interactions, family culture, and the sleeping environment.</p><p>Management typically starts with nonpharmacologic intervention, followed by adjustment of ADHD medications if appropriate, then consideration of specific pharmacotherapy for insomnia in refractory cases.</p><p>In addition, any primary sleep problem (eg, obstructive sleep apnea [OSA] or restless legs syndrome [RLS]) should be carefully investigated and treated since these disorders may cause or contribute to ADHD symptoms. Referral to a specialist may be needed for evaluation and management. (See <a class="local">'Assess for primary sleep disorders'</a> above.)</p><p>Similarly, any coexisting psychiatric disorders should be addressed as they may contribute to the sleep or behavioral symptoms and also inform medication management. Coordination of care with a mental health professional is important, particularly for decisions about pharmacotherapy because of complex effects of psychotropic drugs on sleep. (See <a class="local">'Assess for comorbid psychiatric disorders'</a> above.)</p><p class="headingAnchor" id="H2922435415"><span class="h2">Initial steps</span></p><p class="headingAnchor" id="H700439084"><span class="h3">Establish and maintain healthy sleep habits</span><span class="headingEndMark"> — </span>In children and adolescents with ADHD, an appropriate amount of sleep is critical, within a sleep-wake schedule that remains consistent throughout the week, including weekends  (<a class="graphic graphic_table graphicRef52760 graphicRef120097" href="/d/graphic/52760.html" rel="external">table 3A-B</a>). (See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children", section on 'General guidance to parents'</a>.)</p><p class="headingAnchor" id="H817848784"><span class="h3">Treat behavioral contributors</span><span class="headingEndMark"> — </span>Behavioral contributors to sleep problems are common among children with ADHD and may include problematic sleep-onset associations, inadequate limit-setting by parents/caregivers, or anxiety. If these contributors are identified, they should be addressed as they would be for typically developing children. Some behavioral adaptations may be required for children with ADHD, such as additional warnings and more structured bedtime routines. (See  <a class="medical medical_review" href="/d/html/6353.html" rel="external">"Behavioral sleep problems in children"</a>.)</p><p class="headingAnchor" id="H3130648233"><span class="h3">Establish healthy circadian patterns</span><span class="headingEndMark"> — </span>For children with irregular sleep patterns or delayed sleep-wake phase, the first step is to establish a regular sleep schedule. If sleep onset is significantly delayed, make gradual changes toward the desired bedtime (eg, by advancing bedtime by 15 minutes daily).</p><p>If the sleep-wake phase remains significantly delayed despite these measures, bright light therapy or melatonin may be useful. These therapies are optimally implemented in consultation with a sleep specialist. Bright light therapy, typically consisting of exposure to 30 minutes of bright light therapy upon awakening, is a recommended treatment for children and adults with delayed sleep-wake phase disorder [<a href="#rid55">55</a>], and there is some evidence that it can be effective in advancing sleep phase in children with ADHD [<a href="#rid56">56</a>]. Although only limited evidence of efficacy exists in this population, bright-light therapy is a low-risk intervention. In our experience, evening administration of melatonin may be helpful for sleep-onset insomnia. The combination of bright light in the morning and melatonin in the late afternoon, a few hours before bedtime, is a common regimen in the treatment of delayed sleep-wake phase disorder. (See <a class="local">'Pharmacologic treatment of insomnia'</a> below and  <a class="medical medical_review" href="/d/html/97845.html" rel="external">"Delayed sleep-wake phase disorder"</a>.)</p><p class="headingAnchor" id="H2877487269"><span class="h2">Subsequent management</span></p><p class="headingAnchor" id="H3387898087"><span class="h3">Adjustment of ADHD medications</span><span class="headingEndMark"> — </span>Once healthy sleep habits have been implemented, consider revision of the psychostimulant regimen, such as a reduction in the total daily dose of stimulant, a new formulation, or use of a different psychostimulant or nonstimulant medication for ADHD. As the effects of these medications on sleep vary considerably between individual patients and between different medications and formulations, an individualized trial approach is warranted. (See <a class="local">'Effects of ADHD medications on sleep'</a> above.)</p><p>Decisions about medication changes depend on the child's regimen, primary sleep problem (ie, sleep-onset insomnia or bedtime resistance, sleep-maintenance insomnia, or daytime sleepiness), as well as efficacy for managing the ADHD. Examples of useful strategies include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adjustment of stimulant medications</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For children with sleep-onset insomnia who are on a long-acting stimulant (eg, Concerta, Daytrana, Mydayis, or other <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a> extended-release formulation), change to a stimulant with a shorter half-life (eg, Metadate-ER, Ritalin-SR, or <a class="drug drug_pediatric" data-topicid="103885" href="/d/drug information/103885.html" rel="external">amphetamine sulfate</a> [Evekeo])  (<a class="graphic graphic_table graphicRef80151" href="/d/graphic/80151.html" rel="external">table 7</a>). This will reduce the amount of medication available in the afternoon and should improve sleep onset. For children who are very sensitive to alerting effects of stimulant medication, an immediate-release formulation (eg, methylphenidate, <a class="drug drug_pediatric" data-topicid="13010" href="/d/drug information/13010.html" rel="external">dexmethylphenidate</a>, <a class="drug drug_pediatric" data-topicid="13218" href="/d/drug information/13218.html" rel="external">dextroamphetamine</a>  (<a class="graphic graphic_table graphicRef81815" href="/d/graphic/81815.html" rel="external">table 8</a>)) may be a better option as it further decreases the medication effect later in the day.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Occasionally, sleep-onset insomnia may be due to rebound hyperactivity after the morning dose of stimulant medication wears off. In such cases, addition of immediate-release stimulant in the early- to midafternoon may improve control of ADHD symptoms in the evening and thus improve sleep-onset insomnia. This possibility might be suggested by the history and is established by a treatment trial.</p><p></p><p class="bulletIndent2">Other considerations about adjusting ADHD stimulants are discussed in detail in a separate topic review. (See  <a class="medical medical_review" href="/d/html/16927.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use of nonstimulant medications</strong> – If careful adjustments of stimulant options fail to resolve insomnia, a switch to a nonstimulant medication should be considered.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="13048" href="/d/drug information/13048.html" rel="external">Atomoxetine</a> (Strattera) is moderately effective for ADHD symptoms and is used as a first-line treatment in selected patients, instead of stimulants. Because it does not tend to have adverse effects on sleep, it is a reasonable choice for children with ADHD and insomnia. (See <a class="local">'Effects of ADHD medications on sleep'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Alpha-2 adrenergic agonists such as <a class="drug drug_pediatric" data-topicid="13171" href="/d/drug information/13171.html" rel="external">clonidine</a> or <a class="drug drug_pediatric" data-topicid="15555" href="/d/drug information/15555.html" rel="external">guanfacine</a> are moderately effective for ADHD symptoms in children and adolescents and usually have a favorable effect on sleep onset and maintenance, although this is based on anecdotal clinical experience and a few descriptive or retrospective studies [<a href="#rid57">57-59</a>]. These drugs can be used as monotherapy for the ADHD or in combination with stimulants to both optimize control of ADHD symptoms and regulate sleep. Some clinicians use clonidine or guanfacine in the evening after dinner time or closer to bedtime to achieve the most beneficial results for sleep. Adverse effects may include sedation, lethargy, anticholinergic effects, irritability, and dysphoria. (See  <a class="medical medical_review" href="/d/html/16927.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications", section on 'Treatment failure'</a> and  <a class="medical medical_review" href="/d/html/16642.html" rel="external">"Pharmacotherapy for insomnia in children and adolescents: A rational approach", section on 'Alpha-adrenergic agonists'</a>.)</p><p></p><p class="headingAnchor" id="H1401476306"><span class="h3">Pharmacologic treatment of insomnia</span><span class="headingEndMark"> — </span>If chronic insomnia persists despite careful implementation of each of the above steps, pharmacologic treatment with an hypnotic agent may be an appropriate consideration [<a href="#rid60">60</a>]. The majority of sleep-promoting medications have not been systematically studied in children and adolescents, and the safety and efficacy of these drugs has not been established. No medications are approved in the United States for treatment of insomnia in pediatric patients. Therefore, pharmacotherapy for chronic, persistent insomnia usually should be managed by a clinician with special expertise in managing sleep disorders in children.</p><p>If pharmacologic intervention is planned for chronic insomnia in a child with ADHD, the main considerations are:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Melatonin</strong> – For patients with sleep-onset insomnia or circadian phase delay, melatonin can be used in conjunction with ongoing efforts to optimize sleep habits and treat behavioral contributors. Several small randomized trials and observational studies suggest that melatonin is effective for improving sleep-onset insomnia in children with ADHD, although the quality of the evidence is low [<a href="#rid46">46,59,61-63</a>]. The optimal dose may depend on the type of insomnia:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For sleep-onset insomnia, typical doses for school-aged children are 3 to 6 mg given 30 minutes before bedtime [<a href="#rid46">46,61,64</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For circadian phase delay, lower doses (eg, starting at 0.2 to 0.5 mg) can be given three to four hours before bedtime.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For sleep-maintenance insomnia (night wakings), melatonin is not effective, due to its short half-life. Anecdotal reports describe use of a long-acting formulation of melatonin or administration of another dose of melatonin in the middle of the night upon awakening. However, there is no clinical evidence that this practice increases total sleep time in children with ADHD.</p><p></p><p class="bulletIndent1">Melatonin is not regulated by the US Food and Drug Administration. Over-the-counter formulations may vary in strength and purity and should be used at a minimally effective dose. (See  <a class="medical medical_review" href="/d/html/16642.html" rel="external">"Pharmacotherapy for insomnia in children and adolescents: A rational approach", section on 'Melatonin'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alpha-2 adrenergic agonists</strong> – <a class="drug drug_pediatric" data-topicid="13171" href="/d/drug information/13171.html" rel="external">Clonidine</a> or <a class="drug drug_pediatric" data-topicid="15555" href="/d/drug information/15555.html" rel="external">guanfacine</a> are sometimes used as part of a regimen for ADHD, in part because of their beneficial effects on sleep, as discussed above. (See <a class="local">'Adjustment of ADHD medications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonbenzodiazepine receptor agonists</strong> – Nonbenzodiazepine receptor agonists such as <a class="drug drug_pediatric" data-topicid="13094" href="/d/drug information/13094.html" rel="external">zolpidem</a> and <a class="drug drug_general" data-topicid="8830" href="/d/drug information/8830.html" rel="external">eszopiclone</a> generally improve insomnia in adults. However, two large controlled trials in children with ADHD-related insomnia raise concerns about lack of efficacy and side effects [<a href="#rid65">65,66</a>]. These concerns limit the utility of these drugs in pediatric populations. (See  <a class="medical medical_review" href="/d/html/16642.html" rel="external">"Pharmacotherapy for insomnia in children and adolescents: A rational approach", section on 'Nonbenzodiazepine receptor agonists'</a>.)</p><p></p><p>Further details about pharmacotherapy for insomnia in children are provided separately. (See  <a class="medical medical_review" href="/d/html/16642.html" rel="external">"Pharmacotherapy for insomnia in children and adolescents: A rational approach"</a>.)</p><p class="headingAnchor" id="H3252764943"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113804.html" rel="external">"Society guideline links: Insomnia in children"</a> and  <a class="medical medical_society_guidelines" href="/d/html/117871.html" rel="external">"Society guideline links: Attention deficit hyperactivity disorder"</a>.)</p><p class="headingAnchor" id="H2198966403"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical spectrum</strong> – Sleep disturbances are common among children with attention deficit hyperactivity disorder (ADHD). Common complaints are bedtime resistance, sleep-onset difficulties, night awakenings, difficulty with morning awakenings, and daytime sleepiness. ADHD is also associated with primary sleep disorders such as obstructive sleep apnea (OSA) and restless legs syndrome (RLS). (See <a class="local">'Sleep problems in children with ADHD'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contributing factors</strong> – In some cases, the sleep problem may be caused or exacerbated by environmental factors (eg, poor sleep habits), stimulant medications used to manage the ADHD, or psychiatric or medical comorbidities. (See <a class="local">'Pathophysiology of associations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Evaluation of a child with ADHD and sleep complaints involves:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Characterization of the sleep problem and assessment for behavioral contributors, circadian phase shift, and potential effects of medications  (<a class="graphic graphic_table graphicRef94931" href="/d/graphic/94931.html" rel="external">table 1</a>) (see <a class="local">'Evaluation'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment for primary sleep disorders  (<a class="graphic graphic_table graphicRef111055" href="/d/graphic/111055.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef86837" href="/d/graphic/86837.html" rel="external">table 5</a>), which may contribute to the sleep symptoms or ADHD symptoms (see <a class="local">'Assess for primary sleep disorders'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment for comorbid psychiatric disorders, which may contribute to the symptoms and also inform medication management (see <a class="local">'Assess for comorbid psychiatric disorders'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial management</strong> – Management typically starts with nonpharmacologic intervention, including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Establishment and maintenance of healthy sleep habits  (<a class="graphic graphic_table graphicRef52760 graphicRef120097" href="/d/graphic/52760.html" rel="external">table 3A-B</a>) (see <a class="local">'Establish and maintain healthy sleep habits'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treatment of behavioral contributors (see <a class="local">'Treat behavioral contributors'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Establishment of a regular sleep schedule to entrain circadian patterns (see <a class="local">'Establish healthy circadian patterns'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Next steps</strong> – For some children, adjustment of the timing and formulations of ADHD medications may help to manage insomnia, using an individualized trial approach tailored to the patient's type of sleep problem, current regimen, and response.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ADHD medication adjustments</strong> – Options include use of shorter-acting formulations of stimulants or a nonstimulant medication  (<a class="graphic graphic_table graphicRef80151" href="/d/graphic/80151.html" rel="external">table 7</a>). Occasionally, sleep-onset insomnia may be due to rebound hyperactivity after the morning dose of stimulant medication wears off. (See <a class="local">'Adjustment of ADHD medications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pharmacotherapy for insomnia</strong> – If chronic insomnia persists despite careful implementation of each of the above steps, specific pharmacotherapy for insomnia may be appropriate. For patients with sleep-onset insomnia or circadian phase delay, a trial of melatonin can be considered, in conjunction with ongoing efforts to optimize sleep habits and treat behavioral contributors. For other medications for insomnia, limited data exist on efficacy and safety in children and adolescents. Pharmacotherapy with these drugs usually should be managed by a sleep medicine specialist. (See <a class="local">'Pharmacologic treatment of insomnia'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed, American Psychiatric Association, Arlington 2013.</li><li class="breakAll">International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Available at: https://www.cdc.gov/nchs/icd/icd10cm.htm#FY%202018%20release%20of%20ICD-10-CM (Accessed on November 28, 2017).</li><li><a class="nounderline abstract_t">Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164:942.</a></li><li><a class="nounderline abstract_t">Corkum P, Tannock R, Moldofsky H. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1998; 37:637.</a></li><li><a class="nounderline abstract_t">Efron D, Lycett K, Sciberras E. Use of sleep medication in children with ADHD. Sleep Med 2014; 15:472.</a></li><li><a class="nounderline abstract_t">Sung V, Hiscock H, Sciberras E, Efron D. Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family. Arch Pediatr Adolesc Med 2008; 162:336.</a></li><li><a class="nounderline abstract_t">Owens JA, Dalzell V. Use of the 'BEARS' sleep screening tool in a pediatric residents' continuity clinic: a pilot study. Sleep Med 2005; 6:63.</a></li><li><a class="nounderline abstract_t">Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 2000; 23:1043.</a></li><li><a class="nounderline abstract_t">Fisher BE, Pauley C, McGuire K. Children's Sleep Behavior Scale: normative data on 870 children in grades 1 to 6. Percept Mot Skills 1989; 68:227.</a></li><li><a class="nounderline abstract_t">Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med 2000; 1:21.</a></li><li><a class="nounderline abstract_t">Cortese S, Faraone SV, Konofal E, Lecendreux M. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry 2009; 48:894.</a></li><li><a class="nounderline abstract_t">Hansen BH, Skirbekk B, Oerbeck B, et al. Associations between sleep problems and attentional and behavioral functioning in children with anxiety disorders and ADHD. Behav Sleep Med 2014; 12:53.</a></li><li><a class="nounderline abstract_t">Spruyt K, Gozal D. Sleep disturbances in children with attention-deficit/hyperactivity disorder. Expert Rev Neurother 2011; 11:565.</a></li><li><a class="nounderline abstract_t">Yoon SY, Jain U, Shapiro C. Sleep in attention-deficit/hyperactivity disorder in children and adults: past, present, and future. Sleep Med Rev 2012; 16:371.</a></li><li><a class="nounderline abstract_t">Kapoor V, Ferri R, Stein MA, et al. Restless sleep disorder in children with attention-deficit/hyperactivity disorder. J Clin Sleep Med 2021; 17:639.</a></li><li><a class="nounderline abstract_t">Bruni O, Giallonardo M, Sacco R, et al. The impact of lockdown on sleep patterns of children and adolescents with ADHD. J Clin Sleep Med 2021; 17:1759.</a></li><li><a class="nounderline abstract_t">Çetin FH, Uçar HN, Türkoğlu S, et al. Chronotypes and trauma reactions in children with ADHD in home confinement of COVID-19: full mediation effect of sleep problems. Chronobiol Int 2020; 37:1214.</a></li><li><a class="nounderline abstract_t">Sadeh A, Pergamin L, Bar-Haim Y. Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med Rev 2006; 10:381.</a></li><li><a class="nounderline abstract_t">Golan N, Shahar E, Ravid S, Pillar G. Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep 2004; 27:261.</a></li><li><a class="nounderline abstract_t">Cortese S, Konofal E, Yateman N, et al. Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep 2006; 29:504.</a></li><li><a class="nounderline abstract_t">Youssef NA, Ege M, Angly SS, et al. Is obstructive sleep apnea associated with ADHD? Ann Clin Psychiatry 2011; 23:213.</a></li><li><a class="nounderline abstract_t">Díaz-Román A, Hita-Yáñez E, Buela-Casal G. Sleep Characteristics in Children with Attention Deficit Hyperactivity Disorder: Systematic Review and Meta-Analyses. J Clin Sleep Med 2016; 12:747.</a></li><li><a class="nounderline abstract_t">Lecendreux M, Konofal E, Bouvard M, et al. Sleep and alertness in children with ADHD. J Child Psychol Psychiatry 2000; 41:803.</a></li><li><a class="nounderline abstract_t">Prihodova I, Paclt I, Kemlink D, et al. Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactivity disorder: a two-night polysomnographic study with a multiple sleep latency test. Sleep Med 2010; 11:922.</a></li><li><a class="nounderline abstract_t">Wiebe S, Carrier J, Frenette S, Gruber R. Sleep and sleepiness in children with attention deficit / hyperactivity disorder and controls. J Sleep Res 2013; 22:41.</a></li><li><a class="nounderline abstract_t">Owens JA. Sleep disorders and attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2008; 10:439.</a></li><li><a class="nounderline abstract_t">Beebe DW. Neurobehavioral morbidity associated with disordered breathing during sleep in children: a comprehensive review. Sleep 2006; 29:1115.</a></li><li><a class="nounderline abstract_t">Gruber R. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2009; 18:863.</a></li><li><a class="nounderline abstract_t">O'Brien LM. The neurocognitive effects of sleep disruption in children and adolescents. Child Adolesc Psychiatr Clin N Am 2009; 18:813.</a></li><li><a class="nounderline abstract_t">Becker SP, Epstein JN, Tamm L, et al. Shortened Sleep Duration Causes Sleepiness, Inattention, and Oppositionality in Adolescents With Attention-Deficit/Hyperactivity Disorder: Findings From a Crossover Sleep Restriction/Extension Study. J Am Acad Child Adolesc Psychiatry 2019; 58:433.</a></li><li><a class="nounderline abstract_t">Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Boonstra AM, Kooij JJ, Oosterlaan J, et al. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 2007; 30:433.</a></li><li><a class="nounderline abstract_t">Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study. J Sleep Res 2010; 19:366.</a></li><li><a class="nounderline abstract_t">Sangal RB, Owens J, Allen AJ, et al. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 2006; 29:1573.</a></li><li><a class="nounderline abstract_t">Sobanski E, Schredl M, Kettler N, Alm B. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 2008; 31:375.</a></li><li><a class="nounderline abstract_t">De Crescenzo F, Armando M, Mazzone L, et al. The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis. Atten Defic Hyperact Disord 2014; 6:49.</a></li><li><a class="nounderline abstract_t">Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997; 100:662.</a></li><li><a class="nounderline abstract_t">Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics 2015; 136:1144.</a></li><li><a class="nounderline abstract_t">Stein MA, Waldman ID, Charney E, et al. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child Adolesc Psychopharmacol 2011; 21:581.</a></li><li><a class="nounderline abstract_t">Owens J, Weiss M, Nordbrock E, et al. Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol 2016; 26:873.</a></li><li><a class="nounderline abstract_t">Cheng JY, Chen RY, Ko JS, Ng EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl) 2007; 194:197.</a></li><li><a class="nounderline abstract_t">Faraone SV, McBurnett K, Sallee FR, et al. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther 2013; 35:1778.</a></li><li><a class="nounderline abstract_t">Childress AC, Sallee FR. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder. Drugs Today (Barc) 2012; 48:207.</a></li><li><a class="nounderline abstract_t">Cortese S, Brown TE, Corkum P, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2013; 52:784.</a></li><li><a class="nounderline abstract_t">Van der Heijden KB, Smits MG, Van Someren EJ, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int 2005; 22:559.</a></li><li><a class="nounderline abstract_t">Van der Heijden KB, Smits MG, Van Someren EJ, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007; 46:233.</a></li><li><a class="nounderline abstract_t">Gruber R, Fontil L, Bergmame L, et al. Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHD. BMC Psychiatry 2012; 12:212.</a></li><li><a class="nounderline abstract_t">Becker SP, Kapadia DK, Fershtman CEM, Sciberras E. Evening circadian preference is associated with sleep problems and daytime sleepiness in adolescents with ADHD. J Sleep Res 2020; 29:e12936.</a></li><li><a class="nounderline abstract_t">Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102:616.</a></li><li><a class="nounderline abstract_t">Chervin RD, Ruzicka DL, Giordani BJ, et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 2006; 117:e769.</a></li><li><a class="nounderline abstract_t">Dillon JE, Blunden S, Ruzicka DL, et al. DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy. J Am Acad Child Adolesc Psychiatry 2007; 46:1425.</a></li><li><a class="nounderline abstract_t">Huang YS, Guilleminault C, Li HY, et al. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med 2007; 8:18.</a></li><li><a class="nounderline abstract_t">Amiri S, AbdollahiFakhim S, Lotfi A, et al. Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy and sleep disordered breathing. Int J Pediatr Otorhinolaryngol 2015; 79:1213.</a></li><li><a class="nounderline abstract_t">Picchietti DL, Arbuckle RA, Abetz L, et al. Pediatric restless legs syndrome: analysis of symptom descriptions and drawings. J Child Neurol 2011; 26:1365.</a></li><li><a class="nounderline abstract_t">Auger RR, Burgess HJ, Emens JS, et al. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2015; 11:1199.</a></li><li><a class="nounderline abstract_t">Dahl RE, Pelham WE, Wierson M. The role of sleep disturbances in attention deficit disorder symptoms: a case study. J Pediatr Psychol 1991; 16:229.</a></li><li><a class="nounderline abstract_t">Wilens TE, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1994; 33:424.</a></li><li><a class="nounderline abstract_t">Prince JB, Wilens TE, Biederman J, et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 1996; 35:599.</a></li><li><a class="nounderline abstract_t">Anand S, Tong H, Besag FMC, et al. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. Paediatr Drugs 2017; 19:235.</a></li><li><a class="nounderline abstract_t">Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatr Clin N Am 2009; 18:1001.</a></li><li><a class="nounderline abstract_t">Weiss MD, Wasdell MB, Bomben MM, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006; 45:512.</a></li><li><a class="nounderline abstract_t">Mohammadi MR, Mostafavi SA, Keshavarz SA, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry 2012; 7:87.</a></li><li><a class="nounderline abstract_t">Larsson I, Aili K, Lönn M, et al. Sleep interventions for children with attention deficit hyperactivity disorder (ADHD): A systematic literature review. Sleep Med 2023; 102:64.</a></li><li><a class="nounderline abstract_t">Masi G, Fantozzi P, Villafranca A, et al. Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment. Neuropsychiatr Dis Treat 2019; 15:663.</a></li><li><a class="nounderline abstract_t">Blumer JL, Findling RL, Shih WJ, et al. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. Pediatrics 2009; 123:e770.</a></li><li><a class="nounderline abstract_t">Sangal RB, Blumer JL, Lankford DA, et al. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. Pediatrics 2014; 134:e1095.</a></li></ol></div><div id="topicVersionRevision">Topic 97875 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed, American Psychiatric Association, Arlington 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.cdc.gov/nchs/icd/icd10cm.htm#FY%202018%20release%20of%20ICD-10-CM" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Available at: https://www.cdc.gov/nchs/icd/icd10cm.htm#FY%202018%20release%20of%20ICD-10-CM (Accessed on November 28, 2017).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17541055" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The worldwide prevalence of ADHD: a systematic review and metaregression analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9628084" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sleep disturbances in children with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24684977" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Use of sleep medication in children with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18391142" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15680298" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Use of the 'BEARS' sleep screening tool in a pediatric residents' continuity clinic: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11145319" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2928051" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Children's Sleep Behavior Scale: normative data on 870 children in grades 1 to 6.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10733617" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19625983" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23461477" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Associations between sleep problems and attentional and behavioral functioning in children with anxiety disorders and ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21469929" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sleep disturbances in children with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22033171" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Sleep in attention-deficit/hyperactivity disorder in children and adults: past, present, and future.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33155540" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Restless sleep disorder in children with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33792536" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The impact of lockdown on sleep patterns of children and adolescents with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32856947" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Chronotypes and trauma reactions in children with ADHD in home confinement of COVID-19: full mediation effect of sleep problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16846743" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15124720" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16676784" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21808754" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Is obstructive sleep apnea associated with ADHD?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26951416" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sleep Characteristics in Children with Attention Deficit Hyperactivity Disorder: Systematic Review and Meta-Analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11039692" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sleep and alertness in children with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20817551" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactivity disorder: a two-night polysomnographic study with a multiple sleep latency test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22762354" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sleep and sleepiness in children with attention deficit / hyperactivity disorder and controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18803919" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Sleep disorders and attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17040000" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Neurobehavioral morbidity associated with disordered breathing during sleep in children: a comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19836693" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19836689" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The neurocognitive effects of sleep disruption in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30768404" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Shortened Sleep Duration Causes Sleepiness, Inattention, and Oppositionality in Adolescents With Attention-Deficit/Hyperactivity Disorder: Findings From a Crossover Sleep Restriction/Extension Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31570648" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17520787" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20050995" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17252888" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effects of atomoxetine and methylphenidate on sleep in children with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18363314" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24287735" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9310521" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26598454" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22136094" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27754700" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572882" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24139092" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22462040" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23880489" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16076654" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17242627" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23186226" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31651076" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Evening circadian preference is associated with sleep problems and daytime sleepiness in adolescents with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9738185" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Sleep-disordered breathing and school performance in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16585288" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18049292" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17157069" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26066853" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy and sleep disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21636777" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pediatric restless legs syndrome: analysis of symptom descriptions and drawings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26414986" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2061790" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The role of sleep disturbances in attention deficit disorder symptoms: a case study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8169189" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8935206" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28391425" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19836701" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Pharmacologic treatment of pediatric insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16670647" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22952551" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36603513" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Sleep interventions for children with attention deficit hyperactivity disorder (ADHD): A systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30880992" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19403468" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25266438" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
